文献速递疝与腹壁外科

生物补片与合成补片修复腹壁疝预防复发的PRICE随机临床试验

Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.
PubMed 文献 · Ann Surg · 2021-01-01

该单盲随机对照试验纳入165例腹壁疝患者,随机使用生物(猪)补片或合成(聚丙烯)补片修复,平均随访26个月。意向性分析显示,生物补片组2年复发率39.7%,合成补片组21.9%(P=0.035);污染伤口亚组中生物补片复发率50.0%对合成补片5.9%(交互P=0.041),两组术后并发症率相似。

要点

  • 合成补片组2年疝复发率显著低于生物补片组(21.9% vs 39.7%,P=0.035)。
  • 污染伤口条件下生物补片复发风险更高(50.0% vs 5.9%,交互P=0.041)。
  • 两种补片的术后并发症发生率相似。

核心结论

  • 生物补片修复腹壁疝的复发风险显著高于合成补片,而术后并发症率相似。
  • 在污染伤口条件下也可推荐使用合成补片而非生物补片修复腹壁疝。

研究设计与样本

  • 共纳入165例腹壁疝患者(68例男性),平均年龄55岁,平均随访26个月,按1:1随机分配至生物(猪)补片或合成(聚丙烯)补片组。

主要发现

  • 意向性分析显示,2年时生物补片组25例(39.7%)复发,合成补片组14例(21.9%)复发(P=0.035)。
  • 亚组分析显示污染伤口条件下生物补片组复发率50.0%,合成补片组5.9%(交互P=0.041)。
  • 两种补片的术后并发症发生率相似。

临床怎么用

  • 腹壁疝修补时可优先选择合成补片而非生物补片以降低复发风险。
  • 在污染伤口条件下同样可考虑使用合成补片。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate which mesh type yields lower recurrence and complication rates after ventral hernia repair. SUMMARY BACKGROUND DATA: More than 400,000 ventral hernia repairs are performed annually in the United States. Although the most effective method for repairing ventral hernias involves using mesh, whether to use biologic mesh versus synthetic mesh is controversial. METHODS: Single-blind, randomized, controlled, pragmatic clinical trial conducted from March 2014 through October 2018; 165 patients enrolled with an average follow up of 26 months. Patients were randomized 1:1 to have their ventral hernias repaired using either a biologic (porcine) or synthetic (polypropylene) mesh. The primary study outcome measure was hernia recurrence at 2 years. RESULTS: A total of 165 patients (68 men), mean age 55 years, were included in the study with a mean follow-up of 26 months. An intention-to-treat analysis noted that hernias recurred in 25 patients (39.7%) assigned to biologic mesh and in 14 patients (21.9%) assigned to synthetic mesh (P = 0.035) at 2 years. Subgroup analysis identified an increased rate of hernia recurrence in the biologic versus the synthetic mesh group under contaminated wound conditions (50.0% vs 5.9%; P for interaction = 0.041). Postoperative complication rates were similar for the 2 mesh types. CONCLUSIONS: The risk of hernia recurrence was significantly higher for patients undergoing ventral hernia repair with biologic mesh compared to synthetic mesh, with similar rates of postoperative complications. These data indicate that the use of synthetic mesh over biologic mesh to repair ventral hernias is effective and can be endorsed, including under contaminated wound conditions. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02041494.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Harris HW, Primus F, Young C, et al. Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial. Ann Surg. 2021. PMID: 33443907. doi:10.1097/SLA.0000000000004336

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。